Abstract: . . .  ross.tsuyuki@ualberta.ca This document has been endorsed by the Canadian Pharmacists Association and the Canadian Hypertension Education Program (CHEP) in accordance with the 2006 CHEP Recommendations for the Management of Hypertension . The CHEP mission is to improve the treatment and control of hypertension in Canada. CHEP does not endorse any specific commercial . . .
. . .  mass index (in kg/m 2 ) Contact: Ross T. Tsuyuki ross.tsuyuki@ualberta.ca This document has been endorsed by the Canadian Pharmacists Association and the Canadian Hypertension Education Program (CHEP) in accordance with the 2006 CHEP Recommendations for the Management of Hypertension . The CHEP mission is to improve the treatment and control . . .
. . .  Canadian Hypertension Education Program (CHEP) in accordance with the 2006 CHEP Recommendations for the Management of Hypertension . The CHEP mission is to improve the treatment and control of hypertension in Canada. CHEP does not endorse any specific commercial products.  . . .
. . .  2 ) Contact: Ross T. Tsuyuki ross.tsuyuki@ualberta.ca This document has been endorsed by the Canadian Pharmacists Association and the Canadian Hypertension Education Program (CHEP) in accordance with the 2006 CHEP Recommendations for the Management of Hypertension . The CHEP mission is to improve the treatment and control of hypertension in Canada. . . .
. . .  ) Contact: Ross T. Tsuyuki ross.tsuyuki@ualberta.ca This document has been endorsed by the Canadian Pharmacists Association and the Canadian Hypertension Education Program (CHEP) in accordance with the 2006 CHEP Recommendations for the Management of Hypertension . The CHEP mission is to improve the treatment and control of hypertension in Canada. CHEP  . . .
. . .  30 minutes prior to measurement Have used substances containing adrenergic stimulants, e.g., phenylephrine or pseudoephedrine 2006 Canadian Hypertension Education Program Guidelines for the management of hypertension by pharmacists Page 3 4. Encourage maintenance of ideal body weight (BMI 18.524.9), and weight loss . . .
. . .  ross.tsuyuki@ualberta.ca This document has been endorsed by the Canadian Pharmacists Association and the Canadian Hypertension Education Program (CHEP) in accordance with the 2006 CHEP Recommendations for the Management of Hypertension . The CHEP mission is to improve the treatment and control of hypertension in Canada. CHEP does not endorse any specific commercial products.  . . .
--2819,7,201,3206,14097